U.S. Food and Drug Administration (OPDP / CBER Advertising and Promotional Labeling Branch) · United States

FDA Rx Promotion - Efficacy Claims Not Supported by Substantial Evidence

Promotion may not represent or suggest that a prescription drug or biologic is more effective, more durable or useful in a broader range of conditions than substantial evidence shows.

21 U.S.C. 352(a), (n); 21 CFR 202.1(e)(5)-(6)

What is FDA Rx Promotion - Efficacy Claims Not Supported by Substantial Evidence?

Promotion may not represent or suggest that a prescription drug or biologic is more effective, more durable or useful in a broader range of conditions than substantial evidence shows. Apply to any prescription drug ad, web page, email, social or influencer post or HCP piece that makes a benefit claim.

US Federal

Read official source

Last reviewed: 2026-11-05

General information, not legal advice.

Who does this rule apply to?

general_audience, general_adults_18plus, customers, health_professionals, patients · Prescription Drug · pharma

Where does this rule apply?

United States

Which marketing channels are covered?

all_channels

When does this rule take effect?

2026-10-07

What does this rule require?

Promotion may not represent or suggest that a prescription drug or biologic is more effective, more durable or useful in a broader range of conditions than substantial evidence shows.

How can marketing teams comply?

Apply to any prescription drug ad, web page, email, social or influencer post or HCP piece that makes a benefit claim.

Where can I read the official source?

Read official source

Key facts

Regulatory authority
U.S. Food and Drug Administration (OPDP / CBER Advertising and Promotional Labeling Branch)
Jurisdiction
United States
Official citation
21 U.S.C. 352(a), (n); 21 CFR 202.1(e)(5)-(6)
Published
2026-11-16
Effective date
2026-10-07
Channel
all_channels
Products
Prescription Drug
Audiences
general_audience, general_adults_18plus, customers, health_professionals, patients

Frequently asked questions

What is FDA Rx Promotion - Efficacy Claims Not Supported by Substantial Evidence?

Promotion may not represent or suggest that a prescription drug or biologic is more effective, more durable or useful in a broader range of conditions than substantial evidence shows.

Who does this rule apply to?

general_audience, general_adults_18plus, customers, health_professionals, patients · Prescription Drug · pharma

Where does this rule apply?

United States

Which marketing channels are covered?

all_channels

When does this rule take effect?

2026-10-07

Request a free compliance scan of your homepage and book a time with Warrant.

Get a free homepage compliance scan